GENE ONLINE|News &
Opinion
Blog

2018-05-29|

May 29, 1943: Luria-Delbrück Experiment Published Proving Random Mutations in Bacteria

by GeneOnline
Share To

On May 29, 1943, Italian-American geneticists Salvador Luria and Max Delbrück published the results of the Luria-Delbrück experiment (also known as the Fluctuation Test), demonstrating that the gene mutations in bacteria occur spontaneously and randomly. The experiment shown that, in bacteria, genetic mutations arise in the absence of selection, rather than being a response to selection. Which discovery significantly helped scientists further understand DNA replication and genetic evolution in bacteria, and proved that Darwin’s theory of natural selection acting on random mutations applies to bacteria as well as to other complex organisms. Together with Alfred Hershey, Salvador Luria and Max Delbrück won the 1969 Nobel Prize in Physiology or Medicine for this work.

Reference
https://en.wikipedia.org/wiki/Luria%E2%80%93Delbr%C3%BCck_experiment

Image Source
http://www.discoveryandinnovation.com/BIOL202/notes/lecture15.html

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
R&D
Vaccine Development Has No Limits, the Application Direction of mRNA After the Nobel Prize
2023-10-17
LATEST
Accelerated Bio and Pluristyx Generate Clinical-Grade Induced Pluripotent Stem Cells from Reprogrammed Human Trophoblast Stem Cells
2024-07-12
Novo Nordisk and PT Bio Farma Agree to Enhance Insulin Production for Diabetes Patients in Indonesia
2024-07-12
Alzheimer’s Drug LEQEMBI Approved for Treatment in Hong Kong
2024-07-12
Foreseen Biotech Strikes $1.03B Deal with Ipsen for First-in-Class ADC
2024-07-12
Synthetic Biology’s Innovator Dr. John Cumbers – Addressing Inefficiencies in Biopharma and Economic Sustainability
2024-07-11
Delivering Affordable Biologic Medicines Worldwide: An Interview with Tanvex Chairman and CEO, Henry Chen
2024-07-11
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
EVENT
Scroll to Top